Furthermore, systematic clinical evidence regarding the long-term impact of GLP-1RAs on cancer risk is lacking, creating challenges for assessing the long-term safety of these treatments
The studies we have asked: Does 2.4 mg work better than 1.0 mg? Not: Whats the lowest dose that provides benefit? The Weight Loss Confound: The prosecution says effects disappear when you control for weight loss
The bright and the dark sides of L-carnitine supplementation: A systematic review
We're making healthcare more about you
The lead author of the latest studyPatrick Gleason, Assistant Vice President, Health Outcomes at Prime Therapeuticssaid in an interview with Endpoint News that the real-world data underscore the need for health plans to ensure patients receive comprehensive care, such as case and disease management programs aimed at behavior modification
The study introduces exenatide as a potential solution for ICP reduction in IIH without negatively impacting cognition